KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Neogenomics (NEO) over the last 10 years, with Dec 2024 value amounting to $126.7 million.

  • Neogenomics' Shares Outstanding (Diluted Average) rose 1.15% to $128.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.4 million, marking a year-over-year increase of 1.15%. This contributed to the annual value of $126.7 million for FY2024, which is 0.92% up from last year.
  • As of FY2024, Neogenomics' Shares Outstanding (Diluted Average) stood at $126.7 million, which was up 0.92% from $125.5 million recorded in FY2023.
  • In the past 5 years, Neogenomics' Shares Outstanding (Diluted Average) registered a high of $126.7 million during FY2024, and its lowest value of $111.8 million during FY2020.
  • In the last 3 years, Neogenomics' Shares Outstanding (Diluted Average) had a median value of $125.5 million in 2023 and averaged $125.5 million.
  • Data for Neogenomics' Shares Outstanding (Diluted Average) shows a peak YoY increased of 7.89% (in 2020) over the last 5 years.
  • Over the past 5 years, Neogenomics' Shares Outstanding (Diluted Average) (Yearly) stood at $111.8 million in 2020, then increased by 7.31% to $120.0 million in 2021, then rose by 3.55% to $124.2 million in 2022, then increased by 1.03% to $125.5 million in 2023, then increased by 0.92% to $126.7 million in 2024.